News
-
-
-
COMMUNIQUÉ DE PRESSE
SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations
SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations effective August 2024. With his extensive experience in finance and capital markets, Erfurth aims to enhance SCHOTT Pharma's presence in the capital markets -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Successful 2024 Annual General Meeting of SCHOTT Pharma: Shareholders approve all items on the agenda
SCHOTT Pharma's 2024 AGM sees shareholders approving all agenda items. The company continues on its profitable growth path, focusing on high-value solutions for pharmaceutical trends -